Search Results

Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor.

• Authors : McElree, Ian M.; Packiam, Vignesh T.; Steinberg, Ryan L.

Subjects: THERAPEUTIC use of antineoplastic agents; BLADDER tumors; CABAZITAXELIOWA

• Source: Cancers; Jul2024, Vol. 16 Issue 14, p2561, 12p

Record details

The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer.

• Authors : Chiu, Ching-Feng; Lin, Hui-Ru; Su, Yen-Hao

Subjects: PANCREATIC duct; DRUG metabolism; PANCREATIC cancer

• Source: International Journal of Molecular Sciences; Nov2024, Vol. 25 Issue 21, p11797, 19p

Record details

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.

• Authors : Tsukahara, Shigehiro; Shiota, Masaki; Takamatsu, Dai

Subjects: DIHYDROPYRIMIDINE dehydrogenase; BLADDER cancer; GEMCITABINE

• Source: Scientific Reports; 5/20/2022, Vol. 12 Issue 1, p1-13, 13p

Record details

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review.

• Authors : Mi Ah Han; Maisch, Philipp; Jae Hung Jung

Subjects: CANCER invasiveness; GEMCITABINE; BLADDER cancer

• Source: Investigative & Clinical Urology; Nov2021, Vol. 62 Issue 6, p623-630, 15p

Record details

Inhibition of TRIM32 by ibr‐7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway.

• Authors : Zhang, Bo; Yan, You‐you; Gu, Yang‐qin

Subjects: PANCREATIC cancer; CANCER cells; GEMCITABINE

• Source: Journal of Cellular & Molecular Medicine; Jan2022, Vol. 26 Issue 2, p515-526, 12p

Record details

Tissue- and Temporal-Dependent Dynamics of Myeloablation in Response to Gemcitabine Chemotherapy.

• Authors : Kitelinger, Lydia E.; Thim, Eric A.; Zipkowitz, Sarah Y.

Subjects: MYELOID-derived suppressor cells; PROGNOSIS; TRIPLE-negative breast cancer

• Source: Cells (2073-4409); Aug2024, Vol. 13 Issue 16, p1317, 22p

Record details

Complete response to intravesical gemcitabine in non‐muscle invasive bladder cancer patient after BCG failure: A case report and literature review.

• Authors : Nahhat, Fouad; Doyya, Modar; Ksiri, Hazem

Subjects: BLADDER cancer; CANCER invasiveness; GEMCITABINE

• Source: Clinical Case Reports; Sep2022, Vol. 10 Issue 9, p1-4, 4p

Record details

The Role of Adjuvant Single Postoperative Instillation of Gemcitabine for Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.

• Authors : Koimtzis, Georgios; Alexandrou, Vyron; Chalklin, Christopher G.

Subjects: INTRAVESICAL administration; CANCER invasiveness; TRANSURETHRAL prostatectomy

• Source: Diagnostics (2075-4418); May2022, Vol. 12 Issue 5, pN.PAG-N.PAG, 11p

Record details

Docetaxel/gemcitabine: Lack of efficacy: case report.

Subjects: *DOCETAXEL; *GEMCITABINE; *INTRAVESICAL administration

• Source: Reactions Weekly. Sep2022, Vol. 1922 Issue 1, p234-234. 1p.

Record details

Gemcitabine/oxaliplatin: Lack of efficacy: case report.

Subjects: *OXALIPLATIN; *GEMCITABINE; *ANTIMETABOLITES

• Source: Reactions Weekly. 5/7/2022, Vol. 1905 Issue 1, p221-221. 1p.

Record details